Open an insurer’s investment book expecting moonshots and you’ll be disappointed. It’s not a venture fund. It’s closer to a very patient bond shop that keeps one eye glued to a calendar of when claims will come due. Premiums come in now, promises will be fulfilled later, and the investment job is to make sure the money shows up on the right day without any heroics.
Start with the core idea: liability shape dictates asset shape. A life insurer promises checks decades from now, so it prefers income that arrives on a schedule just as long. That naturally pulls the portfolio toward investment-grade bonds with maturities stretching well past the five-year mark. If you handed a typical life company $100 in its general account, an ordinary outcome is roughly $60 to $70 in high-grade corporates and governments laddered out to match policy cash flows. Another $10 to $20 often lives in commercial mortgage loans and privately negotiated investment-grade credit. Think of this as lending with covenants and call protection that public bonds don’t always offer. Structured credit fills a meaningful slice, around the high single digits to low teens, because amortizing cash flows help fine-tune timing. Equities are a tiny add on, usually just a few dollars, and there’s a small leftover for real estate, alternatives, and cash.
Why that bias? Duration drives demand for insurance companies more than anything. If the present value of a promise has a duration near 10, you want assets that move about the same number when rates wiggle. That keeps the net worth from swinging around just because yields jumped a few basis points. A simple way to picture it: suppose assets and liabilities both have a certain duration. A 1 point rise in rates knocks about 10 percent off each side’s present value, leaving the economic gap close to flat. That’s the quiet superpower of boring bonds aligned to the same schedule as the promises.
Property and casualty (P&C) companies live on a shorter clock. Auto and homeowners claims settle sooner and can surge after a storm, so these portfolios stay closer to the front of the curve and hold more liquidity. Give a plain-vanilla P&C carrier $100 and you’ll usually see about $55 in bonds, but with shorter maturities, a noticeable tilt to municipals because after-tax income matters, and more cash on hand—often near ten dollars—so they don’t have to sell longer bonds to cut checks. Equities show up more here than in life, often in the low to mid teens, because a shorter bond book and underwriting profits can absorb some market noise. The rest gets sprinkled across securitized credit, a bit of real assets, and odds and ends that still pass the smell test of liquidity and predictability.
Health insurers shorten the lens even more. Medical claims roll in continuously and reset with pricing each year, so portfolios look like high-grade, short-duration funds with ample cash and only token equity exposure. The goal isn’t to stretch for yield; it’s to glide through claim cycles without falling on your face.
One important housekeeping point: separate accounts aren’t the same as the insurer’s own risk. Variable annuities and unit-linked products hold assets for policyholders, and those swing with the market. The company earns fees but usually doesn’t take those gains and losses. When people say “insurers own lots of stocks,” they’re often peeking at separate accounts. The general account—the part backing the company’s promises—is the bond-heavy engine we’re talking about.
Of course, there are rules that limit asset allocations. Regulators assign higher capital charges to riskier assets. Equities and below-investment-grade bonds soak up far more capital than an A-rated corporate. Management cares about return on equity, not just coupon, so even a tempting headline yield can look worse after you account for the extra capital it traps. Taxes play referee too. For P&C carriers, tax-advantaged munis can beat same-maturity corporates on an after-tax basis, which is the yield that pays the bills.
Private placements, commercial mortgages, and investment-grade asset-backed securities show up so often because they solve three problems at once. They add a little spread to boost income, they come with structures that sharpen cash-flow timing, and they’re built to be held, which fits buy-and-hold liability matching. The trade-off is they’re harder to sell on a rainy day, so insurers size them knowing their claim clocks and liquidity buffers.
Rates moving around doesn’t flip this playbook; it just changes the details slightly. When yields rise, reinvestment gets sweeter and portfolios gradually roll into higher coupons. When yields fall, the value of those long bonds goes up, but so does the cost of promised guarantees. Duration matching is the shock absorber. Derivatives show up here and there—swaps and futures to tidy up duration or hedge minimum guarantees—but they serve the same master: keep asset behavior married to liability behavior.
If you want a mental model to carry around, use grocery math. For a life insurer’s general account, think something like $65 in long, high-grade bonds, about $15 in commercial mortgages and private credit, around $10 in structured credit, a couple bucks in equities, a couple in cash, with the leftovers in real estate and other small sleeves. For a P&C book, picture roughly $55 in shorter bonds heavy on munis, low-to-mid-teens in equities, about $10 in cash and short paper, and the remainder in securitized credit and small real-asset sleeves. Health skews even more to short bonds and cash. The exact numbers move with markets, underwriting, and regulation, but the order of operations doesn’t change: match the promises first, then let everything else earn its keep around that job.